Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes

This study is currently recruiting participants.
Verified August 2012 by Foundation for the National Institutes of Health
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Merck Sharp & Dohme Corp.
Pfizer
Eli Lilly and Company
Takeda
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Novartis
Information provided by (Responsible Party):
Foundation for the National Institutes of Health
ClinicalTrials.gov Identifier:
NCT01663207
First received: August 9, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)